Results 111 to 120 of about 42,451 (299)
Performance of PML diagnostic criteria in natalizumab-associated PML: data from the Dutch-Belgian cohort [PDF]
OBJECTIVE: To test the current progressive multifocal leukoencephalopathy (PML) diagnostic criteria by applying them to patients previously diagnosed with natalizumab (NTZ)-associated PML in a real-world clinical setting. METHODS: Patients from the Dutch-
Killestein, J +11 more
core +1 more source
Wearable Real‐Time Translation in Rhinology: A Comparative Study of Accuracy and Efficiency
International Forum of Allergy &Rhinology, EarlyView.
Emma J. Anisman +12 more
wiley +1 more source
Development and Validation of the Body Neutrality Questionnaire
ABSTRACT Objective Body neutrality has emerged as an alternative framework within the positive body image literature. This study developed the Body Neutrality Questionnaire (BNQ), the first validated measure of body neutrality for young adults. Method An initial item pool was developed using expert consultation and focus group review.
Amelia Kimpton +4 more
wiley +1 more source
Validation of PML−/− and PML+/+ MEFs.
(A) Western blot showing PML−/− MEFs do not express PML protein. (B) Semi-quantitative RT-PCR also indicated that PML−/− MEFs do not express PML. β-actin served as an internal control.
Elve Chen (392737) +11 more
core +1 more source
Abstract Background Acquired indirect inguinal hernia represents a life‐threatening emergency. Therapeutic decision‐making largely depends on intestinal viability, for which specific predictive parameters (such as venous lactate) have not been evaluated.
Raquel Rivero‐García +8 more
wiley +1 more source
This article reviews the pivotal role of post‐translational modifications of proteins in the development and progression of hematologic malignancies, and explores their clinical translation potential as novel biomarkers and therapeutic targets. ABSTRACT Post‐translational modifications (PTMs) of proteins have emerged as critical regulators in the ...
Yuxuan Han +6 more
wiley +1 more source
Treatment of natalizumab‐associated PML with filgrastim
Objective There is no consensus on the treatment of progressive multifocal leukoencephalopathy (PML) occurring in multiple sclerosis (MS) patients treated with natalizumab (Nz). We report novel immune activating treatment with filgrastim of Nz‐associated
Dusan Stefoski +5 more
doaj +1 more source
Progressive multifocal leukoencephalopathy (PML) is a fatal, demyelinating disease caused by JC virus (JCV) in patients with severe immunosuppression.
Petry, Harald +8 more
core +1 more source
The developing bone was identified as an M2a‐like macrophage driven immune microenvironment with multidimensional developmental signatures. hME‐ApoEVs were successfully fabricated via stimulating the M2a‐like developing microenvironment in vitro and confirmed its recapitulation of developmental features.
Xiaoran Yu +11 more
wiley +1 more source
PML/TRIM19-Dependent Inhibition of Retroviral Reverse-Transcription by Daxx.
PML (Promyelocytic Leukemia protein), also known as TRIM19, belongs to the family of tripartite motif (TRIM) proteins. PML is mainly expressed in the nucleus, where it forms dynamic structures known as PML nuclear bodies that recruit many other proteins,
Jacques Dutrieux +5 more
doaj +1 more source

